deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT00316277

Prescription Opioid Addiction Treatment Study (POATS)

A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Standard Medical Management or Enhanced Medical Management for Opioid Analgesic Dependence

Sponsor: Mclean Hospital

Conditions Opiate Dependence Opioid-related Disorders Substance-related Disorders
Interventions Enhanced Medical Management (EMM) of Prescription Opiate Abuse Standard Medical Management (SMM) of Prescription Opiate Abuse
Updated 6 times since 2017 Last updated: Feb 1, 2013 Started: May 31, 2006 Primary completion: Jul 31, 2009 Completion: Jan 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00316277, this PHASE3 trial focuses on Opiate Dependence and Opioid-related Disorders and remains completed. Sponsored by Mclean Hospital, it has been updated 6 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 21 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mclean Hospital
  • University of California, Los Angeles
Data source: Mclean Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Belmont, United States , Dallas, United States , Everett, United States , Glen Oaks, United States , Lawrenceburg, United States , Los Angeles, United States , Morgantown, United States , New York, United States , Pickens, United States , Roseburg, United States and 1 more location